News

Organic sales rose 1.4% during the quarter, with pricing up 1.5% and volume down 0.1%. The impact of FX was a negative 4.4% ...
Colgate-Palmolive surpassed earnings expectations in Q1 2025, despite experiencing a decline in overall sales.
JP Morgan analyst Andrea Teixeira maintained an Overweight rating and slashed the price target from $99 to $95 on April 11, ...
Shares in consumer products group Colgate-Palmolive (CL) shone brightly in early trading today as it reported forecast beating first quarter ...
Investing.com - Colgate-Palmolive (NYSE: CL) has slashed its full-year guidance for organic sales, becoming the latest ...
Makers of our food and home essentials, including Pepsi and Procter & Gamble, are cutting their financial forecasts for the year and predicting lower sales or profits than before.
Dan Loeb’s Third Point Capital has built a stake in Tylenol and Neutrogena maker Kenvue, becoming the third activist hedge ...
Q1 2025 Management View CEO Noel Wallace highlighted that despite increased volatility in 2025, the company is ...